Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy

Affiliations

• ¹ Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
• ² Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
• ³ Department of Pharmacy, University of Chicago, Chicago, IL, USA.
• ⁴ University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
• ⁵ Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
• ⁶ Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. Electronic address: [email protected].